AREG has been reported to be overexpressed in aggressive forms of cancer, and distinct signaling properties have been reported for EGFR and AREG with respect to endocytosis of ligand-receptor complexes, and initiation of downstream signaling. The gene discussed is AREG; the disease is cancer.